IMDX
Insight Molecular Diagnostics
IMDX
IMDX
26 hedge funds and large institutions have $20M invested in Insight Molecular Diagnostics in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
3.63% less ownership
Funds ownership: 53.6% → 49.97% (-3.6%)
Holders
26
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.13M | |
| 2 | +$379K | |
| 3 | +$78.8K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$31.5K |
| 5 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$26K |
Top Sellers
| 1 | -$765K | |
| 2 | -$29.2K | |
| 3 | -$25.2K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.57K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.13K |